Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| CROSS-LINKING AGENT | Disialoganglioside GD2 cross-linking agent | Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 1 | D008545 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109416 |
CONTENTS